Table 3.
Donor and recipient characteristics according to pancreas transplantation category
| SKPT | SPT | P value | |
| n = 162 in 161 patients1 | n = 40 in 38 patients1 | ||
| Donor age (yr) | 27.3 ± 10.6 | 22 ± 7.6 | 0.004 |
| Donor BMI (kg/m2) | 23.9 ± 1.4 | 23.5 ± 6.8 | NS |
| Donation after cardiac death donors | 5 (3.1%) | 0 | NS |
| Cold ischemia time (h) | 16.2 ± 7.4 | 14.8 ± 3.8 | NS |
| HLA-mismatch | 4.5 ± 1.2 | 2.7 ± 1.5 | < 0.001 |
| PRA > 10% | 27 (16.7%) | 8 (20%) | NS |
| CMV Donor+/Recipient- | 45 (27.8%) | 11 (27.5%) | NS |
| Retransplant | 2 (1.2%) | 14 (35%) | < 0.001 |
| Portal-enteric technique | 147 (90.7%) | 32 (80%) | 0.09 |
| Recipient age (yr) | 42.7 ± 11.3 | 42.2 ± 8.7 | NS |
| Patients aged 50 or older | 42 (26.1%) | 8 (21.1%) | NS |
| Recipient gender: male | 94 (58.0%) | 19 (50%) | NS |
| Recipient: AA | 36 (22.2%) | 3 (7.9%) | 0.03 |
| Recipient weight (kg) | 71.1 ± 13.5 | 70.7 ± 12.8 | NS |
| Dialysis history: hemodialysis | 82 (50.9%) | NA | |
| Peritoneal dialysis | 42 (26.1%) | ||
| None (preemptive) | 37 (23.0%) | ||
| Duration of pretransplant diabetes (yr) | 25.3 ± 9.8 | 26.7 ± 7.7 | NS |
| Waiting time (mo) | 10.1 ± 6.3 | 5.8 ± 7.2 | 0.002 |
1
One patient had 2 SKPTs, two had 2 SPTs, and seven had SKPT followed by SPT. AA: African-American; HLA: Human leukocyte antigen; CMV: Cytomegalovirus; PRA: Panel reactive antibody; SKPT: Simultaneous kidney-pancreas transplantation; SPT: Solitary pancreas transplantation; NS: Not significant; NA: Not available; BMI: Body mass index.